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Chemicals and Cancer in Humans: First
Evidence in Experimental Animals
by James Huff
Certainhumandiseaseshavebeentracedtoexposuretoenvironmentalandoccupational cals. Inmanyinstances
thefirstevidenceofpotential adverse ffectscamefromexperimentalstudiesandweresubsequendydieredinhumans.
Associationsofhumancancers, asadiversegroupofdieases, andchemicak havebeenmadesincethemiddle1700s Since
then, nearly 100chemicls, mixturesofchemicals, orexposure circumstnes are now nied asbeingorstrongly im-
plicatedasbeingcarcinogenictohu_ma Ofthelessthan 00 agenmseval adequatelyfor r yinlb tory
animals, avarying spectrumofdatafromstudiesonhumansareavailableforonlyabout20-25%. Sofar, morethan60
agents arelinkedunequivocally ascausingcancerinhumans, andanother50orsoarestronglysuspectedofbeingcar-
cinogenic tohumans. Notafl ofthesehavebeenorcanbeevaluatedinanimalsbecausesomeareindustrial processesor
"occupations," someareenvironmentalandculturalriskfactors,andsomearemixturesofagents. Forthosethatcanbe
studiedexperimentally, thequalitative concordance betweenhumansandaninalsapproachesunity, andineverycase
thereisatleastonecommonorgansiteofcancerinbothspecies. Theevidenceofcarcinogenidty inexperimentl animals
preceded that observed in hunans for nearly 30agentsandisthesubject ofthis paper.
A risk can be imagined or itcanbe real; it canbeimmediate ordistant.
There are risks that an individual cancontrol, andthoseoverwhich he
or shehas nopower. There arerisksthat havealready resulted frompast
exposures and there are thosethat are predictedfrom exposures which
have nottakenplace. Sensitivitytothesedistinctions iscrucial notonly
for assessing and managing risks, but also for diagnosing and treating
disease. [Rall, 1981 (1)1*
Chemicalscausecancer. Somecausecancerinexperimental
animals. Certainchemicals causecancerinhumans. Fortunately,
notall chemicals areconsideredeitherpotentiallycarcinogenic
to humans (2-4) or to animals (5-9), and the proportion of
chemicals eventually identifiedtocausecancerinexperimental
animals is forecast to be relatively low (10). Occupationally
associated cancers will continue to be discoveredlong into the
future (11,12). Those chemicals identified as being causally
associated with cancers in humans have allbeen shown to pro-
ducecancerinlaboratoryanimals; ineveryinstanceatleastone
siteofcancerwas commontobothmammalianspecies(13-15).
This knowledgetogetherwithpatentsimilarities inmechanisms
ofcarcinogenesisacrossspecies(16-19)ledtothescientificlogic
that chemicals shown clearly to be carcinogenic in animals
(13-15,20,21) should be considered as being likely to present
cancer risks to humans (2,4).
...experimental evidence ... [indicates] ... that there are more
physiologic,biochemical, and metabolic similarities betweenlaboratory
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animaisandhumansthantherearedifferences. Thesesimilaritiesincrease
theprobabilitythat resultsobserved inalaboratory setting will predict
similarresultsforhumans. Clearlytheaccumulatedexperienceinthefield
ofcarcinogenesis supports thisconcept. [RI et al., 1987 (21)]
Forthosechemicals, mixturesofchemicals, orundefinedcir-
cumstances towhichhumansareexposedtoknownorpotential
healthhazards suchascarcinogens, thehallmarkpublic health
issuecentersonwhatlevelofexposure, ifany, willpresentnoor
littlecarcinogenic riskstotheindividuals orpopulations inun-
protected oruniformconditions (22-26). Obviously, ifhumans
arenotexposed to achemicalcarcinogen, thentheexpectation
thatthatchemicalwillbeacarcinogenichazardtohumansmust
be recognized as notbeing readily possible. Yet, even this ap-
parent comfort might be short-lived because other laboratory
chemical curiosities orindustrial intermediates havehad ordo
exhibitwidespreadhumanexposure: examplesarevinylchloride
(27-30), methyl isocyanate (31), tetrachlorodibenzo-p-dioxin
(32,33), and 1,3-butadiene(34,35). Further, theconceptof"safe"
exposurelevelstocarcinogensacceptstheerroneousconceptof
threshold (36).
Ifthresholds do exist and the regulatory decisions are based on a no-
thresholdconcept, therewillbeshort-termeconomic losses. Ifthresholds
do notexistandtheregulatory decisions arebased onthresholds, then
therewillbefewershort-termeconomiclosses,butwewouldfaceafuture
ofdamaged somatic andgerminal DNA and an increased incidence of
neoplastic (andother) diseases. [Rail, 1978 (37]
In this paper, chemicals are identified that were first shown to
cause cancerinlaboratory animals and wereonly subsequent-
lyfoundtobeassociatedwithcancersinhumans. Foreach, the
epidemiological andexperimentalevidence aregiventosupport
this conclusion (2-4,7,8).J. E. HUFF
Butthe issue is notthresholds or nothresholds; itis oneofadding a new
carcinogen to a pool ofpresent carcinogens.
[Rall, 1978 (37)]
Background and Data Sources
In 1979, Tomatis reportedthefirstlistingofchemicalsthatin-
itially were found to cause cancer in experimental car-
cinogenesis studies (13) and at some later time [and perhaps
clinical or epidemiological investigations were stimulated by
these data (38)] evidence ofcarcinogenicity in humans came
forth. Thecollectionofchemicals hasbeenexpanded sincethis
early disclosure (3,14,21,38), and nowincludesupwardsof30
chemicals that arecausally orprobably associatedwith cancer
inhumans wherebythe firstimplication ofcarcinogenesis was
discovered inexperimental animals (Table 1).
Theprimarycollective sourcesofthisinformation comefrom
the IARC Monographs Series (3), the NCI/NTP Technical
ReportSeries (7,8), theDHHSReports on Carcinogens(4), the
IARCSupplement7 (2), Tomatis etal. (14), HuffandRail (15),
Huff et al. (39,40), Vainio et al. (41), and the carcinogenesis
literature. In a few instances wherefore the evidence from
humans has notyetbeenevaluatedbyindependent groups(e.g.,
DHHS orIARC), I havetaken theopportunity tointerpretthe
available findings on reported associations between exposure
and human cancers (15,26); and appropriate references are
given toallowothers tojudgethelevelsofevidence [(42)Table
2]. The agentslisted inTable 1 are notcomplete, andotherswill
surelybeaddedinthefuture. For some, thepossibilityexiststhat
Table 1. Chemicals and cancer in humans: evidence ofcarcinogenicity
first observed inexperimental animals and subsequently by
epidemiologic evidence.
Chemicals causally or probably associated with cancer in humans
1. Acrylonitrile
2. Aflatoxins
3. 4-Aminobiphenyl
4. Analgesix mixtures with
phenacetin
5. Asbestos
6. Beryllium
7. bis(Chloromethyl) ether
8. 1,3-Butadiene
9. Cadmium
10. Chlorination + by products
11. DDT and related compounds
12. Diethylstillbestrol
13. Dibromoethane
14. Ethyl acrylate
15. Ethylene oxide
16. Formaldehyde
17. Gasoline
18. Glass wool
19. Lead and lead compounds
20. Melphalan
21. 8-Methoxysoralen + UV radiation
22. 4,4-Methylene bis(2-chloroanilene)
23. 4,4-Methylene dianiline diHCI
24. Mustard gas
25. Ochratoxin A
26. Phenacetin
27. Radon Gas
28. Silica, crystalline
29. 2,3,7,8-TCDD
30. Vinylchloride
Table2. Humancarcinogens and levelsofevidenceofcarcinogencity.
Level I
Level 2
Level 3
Level 4
Chemicals shownepidemiologically as causally associated with
cancers in humans.
Chemicals shownepidemiologically as possibly associated with
cancers in humans, and confirmedexperimentally as causing
cancers in laboratory animals.
Chemicals shownexperimentally as causing cancers in
laboratory animals
Chemicals shown to exhibit molecular mechanisms similar to
those in levels 1-3
Chemicals = mixtures of chemicals, exposure circumstances, and/or
occupations.
theevidenceofagent-associated carcinogenesis inhumans may
in fact predate the experimental evidence; I would appreciate
learning about any such gaps in awareness, with appropriate
referencecitations. Forsomeotheragentsthelevelofevidence
ofcarcinogenesis in humans may be reflected in case reports
(recallvinylchloride), orinbitsofevidencecumulatedovertime
(e.g., TCDD (43)]. In any event, these are my opinions, and
thosereaders who wishto suggest additions to orsubtractions
from the listing are encouraged.
... positive results in these long-term experiments demonstrate that
achemical is carcinogenic for laboratory animals ...andindicate that
exposure tothechemical has thepotential for hazard to humans.
[Rall et al., 1987 (21)]
Chemicals and Cancer
Since 1971, theInternationalAgencyforResearchonCancer
(IARC), part ofthe World Health Organization (WHO), has
beenevaluatingtheepidemiological andexperimental evidence
for carcinogenicity of chemicals, mixtures of chemicals, in-
dustrial processes, occupations, life-style and cultural habits,
andexposurecircumstances ("agents"). Thiscomprehensive
information and the consensus scientific evaluations are col-
lectedandmadeavailableasIARCMonographsontheEvalua-
tion ofCarcinogenic Risks to Humans. Included in the 57
volumesalreadypublishedorinpressthrough 1992areevalua-
tions or reevaluations on almost 750 agents (2,3,14,41,
44-51). Ofthese750agents, dataonhumanswereavailablefor
onlyabout20-25% [orapproximately 200agents(3,14,15,26,
41,46,47,49,50)].
IARChasthusfaridentified59agentsthatarerecognizedand
accepted widely as being linked unequivocally to human
cancers; thesecanbecollated intofivegroups(3,14,48,50,51):
8 singlechemicals; 10groups(ormixtures)ofchemicals; 19 in-
dividual or combination pharmaceuticals; 13 industrial pro-
cessesoroccupations; and9environmentalorcultural-life-style
risk factors. Tomatis et al. (14) have listed four other en-
vironmental risk factors as causally associated with human
cancers (yet to be formally reviewed by IARC): hepatitis B
virus, human T-cell leukemia virus, ionizing radiation, and
ultraviolet radiation (J. Wilbourn, personal communication).
Thus, atotalof63 agentsevaluatedbyIARCareknowntocause
cancer in humans. An equal or greater number ofagents are
strongly suspectedofposingacancerrisktohumans. Thomatis
etal. (14)haveidentifiedanotherfiveriskfactorsforwhichan
association with the occurrence of human cancer has been
observedalthoughacasual relationhasnotbeenfullyestablish-
ed: Clonorchissinensis, Schistosomiahaematobiwn, Opisthor-
chis vivarrini, Epstein-Barr virus; and papillomavirus (14).
All the single-entity chemicals known to cause cancer in
humans arealsocarcinogenic inexperimental models; impor-
tandy, moreover, ineachcasethereisaconcordanttargetorgan
forcanceroccurrenceinbothhumansandin atleastoneofthe
animal species studied (2,3,14,15,26,41,45-47,50-52). This
correspondence holds likewise for 9 of the 10 groups of
chemicals. Available experimental data on talc-containing
asbestiform fibers are considered inadequate. However, a
nonasbestosformoftalchasbeenstudiedbytheNTPusingthe
inhalation route ofexposure: a spectrum oflung toxicity was
observed, aswerebenignandmalignant tumors ofthe lung in
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female rats, andbenign and malignantpheochromocytomas of
the adrenal gland medulla in male and female rats. No talc-
associated neoplasms were found in mice (K. Abdo, personal
communication). Hence, when comparing chemicals or
reasonably identified groupsormixtures ofchemicals, thecor-
respondence between animals and humans regarding car-
cinogenic activity per se and target sites in particular nears
perfection.
Drugs have full qualitative correspondence andcomparative
target organ concordance on 16 of the 19: methyl-CCNU
(leukemogen inhumans)hasbeenevaluated inonlyonestudy in
rats, wherein lung is a suspected target organ; MOPP (as the
combination)andTreosulfan (bothinduceleukemiainhumans)
haveeither inadequateexperimental dataornodataatall. (The
latter alkylating chemical undergoes metabolism to diepoxy-
butane, knownascarcinogenic toanimals). However, twoofthe
four components ofMOPP do induce cancers in experimental
animals: M (mechlorethamine, nitrogen mustard), lung, lym-
phoma, andskin; 0(Oncovin, vincristine); inadequatestudies;
P (procarbazine), nervous and hematopoietic systems, mam-
mary, hemangio- andosteosarcomas, andlung; P(prednisone),
inadequate studies. Many of these carcinogenic drugs are
alkylatingcancer-chemotherapeutic agents, oftenifnotalways
resulting in secondary cancers after orduring long-term treat-
mentofprimary cancers(53-55). Althoughtheyareimmediately
useful andlife-saving, thesecancerchemotherapeutic agentsdo
causetoxicityatthehighdosesusedandalltoofrequently even-
tually lead tocancer in other organs.
Once we have identified a hazardand estimated the risk, we must then
determinewhetheritissociallyacceptable, and ifso, atwhatlevel. But
inconsidering thisweare nolonger inthe realmofthescientist. This is
adecisionthat should bemadethroughourpolitical process. Atbest, it
should be based upon firm scientific data andclearly articulated social
and economic values.
[Rall, 1981 (1)]
UndefinedExposureCircumstances
Forthe 13 processesoroccupationsassociatedwithcancerin
humans, none have been evaluated properly in whole-animal
laboratory experiments (3,14,15). Other than using sentinel
animals intheoffendingoccupationalsettingorcatchingandex-
aminingnativemammalian oravian stock, thedesignand con-
ductof"mimicexperiments" ontheseprocessesarenotlogically
feasibleorlogistically possible. Onesimplyhastodesignmore
innovative experimental protocols tobetterevaluatelikely cor-
respondence in animals. Environmental sentinels have proven
useful foridentifying "carcinogenicenvirons," suchasfishwith
liver tumors in Boston Harbor andelsewhere (56).
Theeight "life style" agents so faridentified ascausingcar-
cinogenesis in humans have good complementation among
species; however, neither alcoholic beverages nor smokeless
tobaccohasbeen studiedadequately inlaboratoryanimals. Ex-
perimental study ofalcoholic beverages presents aunique and
perhapsbafflingdilemmaofnotonlydecidinghow todesigna
"definitive" experiment(sincethecarcinogenic agentoragents
have not been identified), but most importantly to which
"cocktail" should the animals be exposed? Onetheory asserts
thatethanol maysimplybean "irritantpromoter" actinglocally
(e.g., esophagus) asacell stimulatorygrowth factor, thusbeing
an "application-site" carcinogen. Some suggest that ethanol
may be a co-carcinogen. Others believe that the causative car-
cinogen resides in the "nonalcoholic" portion of the spiritus
frumenti. Perhaps experiments should be designed not using
ethyl alcoholalone, butasapotentialpromoterorcocarcinogen
(with what?) or better yet expose animals to the "alcoholic
beverages" thathumans actually drink. Thiscan bedone rather
easily, but the mixture selected would somehow have to be a
"universal drink." As anexample, onecould identify thetop 10
brandsconsumed (liquors, beers, orwines, orevenacombina-
tionofthese three)and then concoctanexposure regimen mix-
ture. This mayormay notprovide thefinalordefinitiveanswers,
butsuch anexperiment wouldhelptoevaluateandvalidateonce
againthehuman-surrogate animal model. Until nowlimited data
exist (57) to implicate ethylalcohol aloneasbeingcarcinogenic
to laboratory animals (5S). Nonetheless, alcohol beverages have
been shownconclusively asbeing carcinogenic tohumansforthe
oral cavity, pharynx, larynx, esophagus, and liver.
Outofthe63 agents considered tocausecancer inhumans, 44
have or could be studied in long-term experiments using
laboratory rodents; the 13 processes cannot. All 39 human
carcino-gensthathaveundergoneadequate experimental studies
havebeen showntocausecancer inanimals, andexhibitconcor-
dancefortumorsites (14,26,45,47). Forthefivethatmayappear
to show a lackofagreement, three areconsideredtohave been
studied inadequately (methyl-CCNU, MOPP, talc with
asbestiform fibers) and two have yetto beevaluated in animals
(alcoholic beverages and treosulfan).
Further, IARC has identified an additional 41 chemicals,
groups ofchemicals, or industrial processes thatare probably
carcinogenic to humans and sufficient evidence in animals, 8
have limited evidence in humans and no or inadequate data in
animals(2,3,14), 16havelimitedevidenceofcarcinogenicity in
humans, whereastheother28wereplacedinthiscategorybased
largelyonsufficientevidencefromstudiesinlaboratoryanimals.
Another 205 agents have been designated as possibly car-
cinogenic to humans; 9 ofthese had limited evidence of car-
cinogenicity in humans. Therefore the available human and
animaldatathathavebeenevaluatedshowthatatleast96agents
(i.e., 59 + 16 + 8 + 9 + 4)areconsideredtohavesufficientor
limited evidence ofcarcinogenicity in humans. Perhaps these
shouldcollectivelybeconsidered ascausingcancer inhumans,
especially since appropriately sizedhuman cohorts forconfir-
matory evidence are most frequently unavailable.
ComplementarytotheIARCeffortandinresponsetotheU.S.
Congress, the National Toxicology Program (established in
1978), partofthe Public Health ServicewithintheDepartment
ofHealthandHumanServices, publishesanAnnual Reporton
Carcinogens(4). Thesereportscontainaseriesofmonographs
onsubstancesdefinedunderU.S. PublicLawthat "areknownto
becarcinogenic tohumansorthatmayreasonablybeanticipated
tobecarcinogenic" (tohumans) (4). Selectionofcandidateen-
tries are based typically on scientific criteria similar to those
developed and adopted by IARC. These DHHS monographs
summarize the available evidence of carcinogenicity in both
humans (where available) and in experimental animals and
review any regulatory actiontakenonaparticularsubstanceor
mixtureofsubstances. IntheSixthAnnualReport(4), forexam-
ple, there are 25 substances, groups ofsubstances, or techno-
logical processes designatedasbeingcarcinogenic to humans,
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andanother 148thatmayreasonably beanticipated asbeing car-
cinogenic to humans (4).
Pbssibledifferences betweenthe 110agents listedby IARCand
the 180 substances renderedby the DHHS centerlargely onthree
reasons: a) chemicals not yetevaluatedby onegroup may have
beenconsidered andaddedbytheother,b) DHHSdoes notusu-
ally prepare individual monographs onprocesses oroccupations
(these areoftenmentionedinthe introductory section totheRe-
ports), andc)the "may reasonablybeanticipated" substances as
definedby DHHSmaycontain someofthe205 agentsthatIARC
has classified as 2B (possiblycarcinogenic tohumans). By-and-
large there is considerableconsistency among the two listings.
Otherimportant sourcesoflists ofagents believedtobeassoci-
ated with human cancers are the European Communities (59)
and theCaliforniaDepartmentofHealth(60),bothofwhomhave
publishedindependent, consensusanalysesoftheavailabledata.
The questionofspecies-to-species differences in response to chemical
carcinogenesis is fundamental to attempts to reduce the incidence of
cancer in manby insuring that those chemicals to which man is or will
beexposed are not carcinogens.
[Rall, 1977 (6I)]
Chemical Carcinogenesis
Clearly, the accumulated experience in the field ofcarcino-
genesis supports the concept that cancer development is a
multistep process and that multiple genetic changes are often
considered to be required before a normal cell becomes fully
neoplastic (62-64). Bannasch et al. (65) definecarcinogenesis
"(as being) characterized by sequential molecular, metabolic,
andmorphologicalchangesthatresultin adeficiencyofcellular
differentiation and a loss ofnormal growth control." This has
been endorsedby Lijinsky(66), who insiststhat "Chemicalcar-
cinogenesis is a processdrivenby thereactivity ofthechemical,
and ...the interaction ofthecarcinogen with critical molecules
in certain cells, some of which go on...to self-perpetuating
cancercells." Likewise, studiesofhuman tumors suggestthein-
volvementofamultistepparadigmtogetherwith similargenetic
events asoften occurin thedevelopmentofcancerinanimals. In
any event, an increasing number of individuals question the
dogmasurroundingdifferentiationofchemicalcarcinogensin-
to discrete genotoxic-nongenotoxic mechanisms ofcarcinogen-
esis (67), in that "It is difficult to consider... that the critical
molecule has to be DNA, which (can be) adducted similarly
whether tumorsarise ornot" (66,67). And "thatmoreattention
to the remaining wondrous structure ofcells, and the changes
produced in it by carcinogens, will lead to a (better) under-
standing ofthegenesisofcanceranditsprogression" (66). Given
the expanding numbers of nongenotoxic carcinogens being
discovered leads one to supportthe notionthatperturbationsof
DNA may not be the singular initiating event in chemical car-
cinogenesis. Obviously more effort is needed.
Properly conducted animal studies have beenshown tobepredictivefor
carcinogenicity andtoxicologic responses in humanpopulations.
[Rall, 1979(68)]
Animals toHumans
From the informationcurrently available, the arrayandmulti-
plicity ofcarcinogenic processes arevirtually commonamong
mammals, forinstancebetweenlaboratory rodentsandhumans.
Zbinden (69), for example, believes that "the more we know
about the similarities of structure and function of higher
organismsatthemolecularlevel, themoreweareconvincedthat
mechanismsofchemicaltoxicity are, toalargeextent, identical
inanimalsandman." Centeringonthecarcinogenesisparadigm,
Bertrametal. (17) state "Thereisoverwhelmingevidencethat,
atthecellularlevel, humans... .donotdifferqualitatively from
experimentalanimals intheirresponsetocarcinogens. Further-
more, processesoperativeinhumansthatleadtocancerinduc-
tionarealsooperative in rodentsystems." Most scientistsagree.
Theforegoingplustheknowledgethatall chemicalsknownto
induce cancerinhumans, thathavebeen studiedunderadequate
experimental protocols, alsocausecancer in laboratory animals
lead mostprudentinvestigators tothepersuasive speculationthat
theobversewouldsimilarlyholdtrue: chemicals showntoune-
quivocally induce cancerin laboratory animals should be con-
sideredcapableofcausingcancerinhumans. TheInternational
Agency for Research on Cancer adopted this widely accepted
scientific view: "In the absenceofadequatedata onhumans, it
isbiologically plausible andprudent to regard agents and mix-
turesforwhichthere is sufficientevidenceofcarcinogenicity in
experimentalanimals as iftheypresented acarcinogenic riskto
humans."
Nonetheless, this biologic conundrum of scientific debate
regardingthepredictability ofexperimental findings will sure-
ly continue. One difficulty ofcourse resides in our individual
definitions of "carcinogen," and this led Yamasaki (70) to ad-
monish us that "Terminology itselfdoes not advance science;
however, themisuseofterminology sometimeshindersthepro-
gress of science." Of course others have urged clarity much
earlieron. Inthesecondcentury forexampleGalenwrote "The
chiefmerit oflanguage isclearness, and we know that nothing
detracts somuch fromthisasdounfamiliarterms." As we some
timesappeardriven todefineandre-define termsandconcepts,
Zwickey and Davis (71) gave us a "pre-mechanistic" succinct
definition of chemical carcinogenicity that still serves well:
"Carcinogens arethose substances whichproduceasignificant
increase in tumor(cancer) incidencewhenadministeredatany
dosage level by any route of administration in any species of
animalascomparedto(concurrent)conrols." Oneofcoursemust
becareful tocomparecarcinogens onthecollective strength of
the response, since all chemical carcinogens can not be con-
sideredequal (25,38).
Furthertherearepoliticalmotivesthatsome seemtouseasa
means to discredit experimental carcinogenesis results. Some
misleadinglystatethateverythingiscarcinogenic(72), andlabel
as carcinogenic chemicals (e.g., allyl isothiocyanate or d-
limonene)thosethatdonotfittheinternationallyaccepteddefini-
tions (2-4,73), andtherebyhinderingourunderstanding ofthe
scienceandtheprotectionofhumanhealth. Naturallythisleads
toconfusionamongtheadministratorswhomustcopewiththese
dichotomousscientificviews; yetthisseemingpredicamentcan
be easily overcome ifone would concenrate on the listings of
chemicals identifiedaspresentingmostlikelycancerhazardsto
humansbyorganizationsthathavetheappropriateexpertiseand
who involve groups of experts in carcinogenesis and related
disciplines(e.g., IARC andNTP/DHHS), ratherthanonthose
a) who have never participated in the consensus evaluation
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process wherein all the available data and information are
critically evaluatedbeforemaking aninterpretation; b) whohave
neverdesigned or conducted such large-scale and intricatelong-
term experiments; c) who never evaluated thetotality ofthe ex-
tensive experimental data; d) who may comment-for-gain; or e)
who have only individual opinion. Moreat issueofcoursearethe
eventual social, political, and regulatory uses of these ex-
perimental findings ofcarcinogenesis. Some continueto exhibit
confusion in separating the scientific and biologic results from
the nonscientific applications and from the mathematically
oriented risk assessment models, all of which struggle with
assigning numerical (and often esoteric) values ofprobability.
Dodgson (74) dealt effectively with this by explaining, "Con-
trariwise, ifit was so, it might be; and ifit were so, it would be;
but as it isn't, it ain't. That's logic." Thus, one doesbetter to re-
ly more on experience, objectivity, and consensus ratherthan on
individuals who may have a conflict-of-interest or a misunder-
standing on the particular agent being evaluated.
Thus, we need to concentrate on rising above the fray to do
what is right for society and not on some vague notions about
how many deaths can weaccommodate ortolerateateach incre-
mental exposure scenario. Until the quantitation exercises being
promoted become a real science, onemight do well to consider
(or actually return to) the qualitative concept ofsimply not ex-
posing peopleto hazardous chemicals or insidious exposure cir-
cumstances. One would think this would be easy. As one exam-
ple, EPA reports (75) that734 U.S.corporations havepledged to
reduce emissions of 17 high-priority toxic chemicals by 304
million pounds; actually this is minisculewhen oneconsiders the
total released pollution burden, but even this amount equals
10,000 fully loaded52-foottankertrucks thatend-to-end would
stretch for 100 miles! Nonetheless, consider that a single
chemical used in the rubber industry is pumped into the at-
mospheric environment at the astonishing rate (in the United
States alone) of nearly 10 million pounds per year (34,35).
Moreover, in 1989 the EPA's toxic releaseinventory(based on on-
ly 328 chemicals) reported that a total of 18 billion pounds of
these toxic pollutants wereemittedby 19,000industrial facilities
(or 75 pounds forevery person in the United States) (I. Cote, per-
sonal communication) Massivepollution will likely continue in-
definitely and will increase aswell, especially becausedevelop-
ing countries are being used more and more frequently as
geographic areas in which much chemical production takes
place, often with less stringentsafeguards orsafetyprecautions.
Considerableeffort should be mounted toquell this unfortunate
and environmentally unhealthy rend.
It is ourjob as scientists toattempt, as best wecan, to look intothefuture,
see the changesahead, and anticipatethe side effects ofthese changes.
But we know frompastexperiencesthatthere are fewimportantanduseful
discoveries thatdo nothave someunanticipated, undesirable sideeffects.
It isourresponsibility toalert leaders inpublicpolicy and suggest tothem
how we might prevent or minimize any negative health consequences.
[Rail, 1990(76)]
Discussion and FurtherCommentary
Social andpolitical debatebeginswhenchemicals areshown
unequivocally to induce cancer in laboratory animals and no
relevantorreliable humandataexisttoconfirm ortocounterany
association. Differencesin scientificopinion, wherethey occur,
generally rest notontheactualexperimental findings but a) on
theinterpretationofthedata, b) onthe system ormodel used to
generatethedata, c) onthepersonororganizationconductingthe
investigations or reportingthefindings, d) theforecasteconomic
oremploymentaspects, andtheeventual impact these findings
will have on our personal and occupational environments. As
long as thesedata are used to stimulate the regulatory process,
thepolitical, social, public, and scientificdebates willcontinue
(at timesalmostregardlessoftheactual facts). Nonetheless, this
array ofopinionatedthoughtusually benefits all sides ofa par-
ticularissue,andoftenresults inscientificallybasedcompromise
and a morescientificallyobjective consensus. Ideally, onewould
hope that no personal interest in the benefits or economics of
chemicals wouldcomeintoplaywhenconsideringthe scientific
evidenceofcarcinogenicity. Public, individual, andenvironmen-
tal health are too important.
The clear understanding and universal awareness that all
chemicals known to induce cancer in humans, that have been
studied underadequateexperimentalprotocolsalsocausecancer
in laboratory animals convince mostprudent investigators and
reasonably thinling scientists and regulators to the persuasive
speculationthattheobversewouldsimilarlyhold true: chemicals
shown to unequivocally induce cancer in laboratory animals
should be considered capable ofand likely to cause cancer in
humans. Thispublic healthposition has servedwelland should
continue. Nonetheless,thescientificdebateswillsurelycontinue.
As more and more advancements aremade in molecular car-
cinogenesis, ourunderstandingofthemechanismsofcancer in-
ductionwithinthemammaliandomainwill allow ustoshed more
light on the valueofusing animals aspredictive surrogates for
humans (16-19, 67,77). This will predictably furtherpermit us
to more closely approach the public health objective of pre-
venting, substantially reducing, or virtually eliminating the
burdenofchemically inducedandchemically enhanced cancers
in humans (36,78,79).
Ifanexperimentyields aclear-cutnegativeresult, there is littlediscus-
sionaboutthe meaning orthemeaninglessnessofanimal studies. When
aclear-cutand strongpositiveresultoccurs, thereisalsolittlediscussion.
Whenthe result is a slightly positiveexperiment, interpretation becomes
difficult and discussion becomes lengthy. Biology, unfortunately, does
not comeonly inblack orwhite, but in many shadesofgray, and inthese
gray areas disagreement is particularly evident.
[Rall, 1988 (52)]
Experimental Chemical Carcinogenesis: First
Evidence
Because epidemiological data are often absent or past ex-
posuredata areunavailable, public healthdecisions must con-
tinuetobebasedlargely onanimaldata. Historically, thislogical
concepthasservedthepublicwell aspreventivemedicine. Thus,
while we hope that subsequent epidemiologic studies on the
recognized animal chemical carcinogens do not identify addi-
tional causal associations with human cancer, these chemical
carcinogenesis results in laboratory animals frequently if not
almostalways constitutetheprimary basis for identifying and
predicting potential human health hazards (17,20,21,24,36,
78-80). Severalchemicals identifiedfirst ascausing cancer in
laboratory animalsshowassociationswithhumancancers. For
instance, 1,3-butadiene, thepotentrodentcarcinogen(81-84),
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Table 3. Chemicals that are candidates for furtherevaluation
as humancarcinogense.
Chemical Cancer References
1,3-Butadiene Leukemia (85-87)
Hair dye Leukemia/lymphoma (88-90)
Chlorinated drinking water Urinary bladder (91,92)
Sulfuric acid/acid mists Lung (93,94)
Dimethylformamide Testicular (95-98)
Ethylene oxide Leukemia (99-102)
Ethylene dibromide Lymphoma (103,104)
Formaldehyde Lung (105-113)
Acrylonitrile Lung (114-118)
Methylene chloride Liver (119-12I)
4-Chloro-o-toluidine Urinary bladder (122)
2,4-D Non-Hodgkins lymphoma (123-127)
Ethyl acrylate Colon, rectum (128)
Aviation gasoline Kidney (129,131)
DDT and related products Pancreatic (132,133)
'Some ofthese chemicals have been placed into Table I as associated with
human cancers. See also references (2-4).
has beencausally associated with thedevelopmentoflymphatic
and hematopoietic cancers inhumans(85,86). Inanestedcase-
control studyofthestyrene-butadiene rubberindustry [note: the
rubber industry as a whole is considered a human carcinogen
(2,3)j, Matanoski et al. (87) found that leukemia cases were
associated with exposure tobutadiene (odds ratio = 9.4; 95%
confidence interval = 2.1-23).
Certain other chemicals with strong animal data and in my
view adequate humanevidence seemtobeprimecandidates for
further evaluation as human carcinogens (Table 3).
Asstatedby Doll(11,12), thefinal numberofprovenoccupa-
tional (andenvironmental) carcinogens mayeventually bequite
large. Thus wemustcontinue inourscientificandpublichealth
efforts to identify potentialcarcinogenic hazards tohumans, and
forthose agents thatareconsidered toinflict undueharmthese
should no longer be permitted unregulated exposures.
Regarding causes ofcancer in humans, Doll and Peto (136)
argued that the causes of 97% of human cancers can be ex-
plainable, with alargeproportion (10-70%; bestestimate,35%)
due todiet. Usingthe mostrelevantandcommonsitesofhuman
cancer, Schmahl et al. (135) estimate only one-third of the
cancers (in the Federal Republic ofGermany) can beassigned
ecologically to exogenous carcinogenic agents or lifestyle.
These latter authors stress that indirect primary prevention,
basedontheprobable summaration ofsubcarcinogenic effects
ofsingle carcinogens identified fromanimalexperiments, may
lead toa reduction ofcarcinogen-induced cancers eveniftheef-
fects of a particular carcinogenic compound cannot be deter-
minedprecisely. Regardingtheinfluenceofdietontheincidence
andmortalityofcancer, Schmahl etal. (135)agreewith Byers
and Graham (136) who indicate thatthe relationship between
dietary factors and cancer increases has not revealed a single
unequivocal conclusion ofcausality.
Most followers ofthediet-causality theme appear to simply
default this notion without unequivocal supporting evidence,
oftendrivenbythedifferentcancerstypesoccurring indifferent
continental locations (137-140). Ifoneexamines theincidence
ormortality maps oftheUnited States forexample, clustering
orpocketsofcancersareperhapsthemoststrikingobservations.
Do these distributions impugn diet as causal? Or must we in-
vestigate these "local outbreaks" ratherthan ascribing dietas
the ultimatede facto carcinogen. As Boyland (141) so cogent-
ly stated, "Cancer, likeother natural phenomena, has causes.
Whenatumorisdescribedasbeingspontaneous(orascribedto
dietary influences) it means that thecauses are unknown, like
thoseofmosteventswhichoccurinlivingthings." Alsothecon-
tradictory dichotomyofepidemiologicresults (e.g., fatsprotect
against or cause cancer) simply adds to the confusion.
All agents identified as causing cancer in humans have
likewise beenshown to cause cancer in laboratory animals. A
keybiological andpublichealthquestionthatseemstodominate
the interactions of research, regulatory, and industrial com-
munities around the issue of cross-species extrapolation of
chemcalcarcinogenesis findings. Inmyview, andonesharedby
most, the preponderance of evidence supports the logic that
chemical-induced toxicity [e.g., Zbinden (69)] and car-
cinogenesis [e.g., Bertram et al. (17)] are sufficiently and
(un)remarkably similar among mammalian species, although
one (toxicity) does not forecast the other (carcinogenesis)
(142,143). Thusonewouldremainscientifically soundtocon-
tinuetopredictcarcinogenichazardsforhumansbyusingresults
obtained fromlong-termchemicalcarcinogenesisexperiments.
Nonetheless, because chemicals inducing carcinogenic re-
sponses inanimalsshouldnotbeconsideredempiricallyequal,
onewouldbeill-advisedtosimplydivideallchemicalsintotwo
motley groups: carcinogens or noncarcinogens. One needs to
evaluateandcomparea)theavailablepublishedcarcinogenesis
data (e.g., the IARC Monographs process) or b) the actual
experimental data and interpretations (e.g., the public peer
reviewsystemoftheNTP)andtherebyestablishaconsistentand
consensus evaluation process. In this manner one begins to
gatheranddevelopastorehouseofcarcinogenesisdatathatper-
mits placing chemicals into generic groups based largely on
qualitativepotencies. Appropriate levelsofqualitativeevidence
fordetermining chemically orenvironmentally associated car-
cinogenesis inhumanscanbedividedintoatleastfourgeneral,
andattimesoverlapping,classes(Table2). Addedtothesesim-
plifiedgroupings onemustconsiderotherrelevantdataaswell;
thatis, usinga "weight-of-evidence" approach(21,42) that, for
example, takes into account the strength of the carcinogenic
response in experimental animals (6). In addition, all car-
cinogens arenotequal intheircarcinogenicity (e.g., Table4)or
intheirpotentialtoposeacancerhazardtohumans. Conversely,
inmyopinion, onecannotmakeacarcinogen outofaninnately
noncarcinogen (orcarcinogen intoanoncarcinogen) simply by
manipulatingtheexperimental conditions orfurther, orby alter-
ing the protocol designs (e.g., using so-called high doses).
Likewise, oneshouldnotattempttolabel acarcinogen asanon-
carcinogenbecausehumansmaybeexposed tolevelsbelow or
Table4. Distribution ofcarcinogenic responses for326chemical studies
(male rats, femalerats, male miceand female mice).
Positive in sex-species +/Total %
+,+, +,+(4 of4) 45/326 14
+,+,+, - (3 of4) 26/326 8
+,+,-,-(2 of4) 60/326 18
+,-,-,- (I of4) 39/326 12
- (Oof4) 156/326 48
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Table 5. Major public health issue.
Fact: All exposures identified as being carcinogenic to humans that
have been studied adequately havebeen shown to cause cancer in
experimental animals at minimally toxic exposures.
Question: Will all identified animal carcinogens cause cancer inhumans?
Answer: Probably not, but the answer remains to be discovered. For some
(too many), we must say yes.
even considerably below those concentrations which induced
carcinogenesis in animals. Importantly, we need to remember
thatthese long-term experiments areconducted undersomewhat
artificial conditions: single chemical exposures (whereas
humans receive myriad carcinogens from multiple and varied
sources); only two species ofrodents, relatively few animals;
most often exposure begins in adulthood (and not preconcep-
tionally orprenatally); thetestsareforidentifying weakorcocar-
cinogensorpromoters, andtheduration istypically lessthanop-
timum for discovering late-acting carcinogens. Nonetheless,
becausemostchemicals arenotorwill notbe "real" carcinogens
(2-4,9,10), thosethataremustreceiveduecautionary attention
(Table 5).
Thedecades-oldquestionremains: howconfidentshouldwe
bethatconsensusexperimental carcinogens will predictcancers
in populations exposed to the same chemical or exposure cir-
cumstance? History, biology, andthethemeofthispapercertain-
ly supporttheconceptofextrapolatingcarcinogenesis findings
fromanimalstohumans. Evenmorebasic, willchemicalsshown
conclusively to cause cancers in laboratory animals also even-
tually be foundtocausecancerinhumans(Table5)?Ignoring for
the momentthe important and controversial issueofexposure,
the answer is yes. The object correctness and prudency ofthis
responsecomenotonly fromtheobviouscross-mammaliancon-
sistencybutfromknowingthatnearlyone-thirdofthoseagents
considered carcinogenic to humans were discovered first in
animals.
...a commitment todeal with this problem(ofchemical-hazards) buys
us intoahighlyimprecise worldofinadequatedataandconflicting values.
Notonly isthe information incomplete, but ifwedoanticipate hazards
andthereby prevent futuredisease, wewill neverknowthatweareright.
In factthe naysayers will tell usthat wecannotdemonstrate that we were
right, precisely because we are not willing to allow the evidence to ac-
cumulate. Inshort, theprice wepay forbeingrightisthatwecannotprove
that doing nothing was wrong.
[Rall, 1981 (2)]
Datareportedhereinshowthatnearly25-30% ofthoseagents,
substances, or chemicals that have been causally or strongly
associated with cancer inhumans were first identified asbeing
carcinogenic inexperimental animals. Ifmoreattention would
havebeengiventothesefindings, perhaps someunduesuffering
anddeathcouldhavebeenavoided. Likewiseforthosechemicals
shown tocausecancerinlaboratory animalsthathave notasyet
had undergone epidemiological investigations, one should
reduceoreliminate all unnecessary exposures. Meanwhile co-
horts being exposed to these agents should be identified and
evaluated. Tocontinue toignore experimental data for reasons
ofuncertainty must no longer be tolerated orcondoned.
NOTEADDEDINPROOF: Suppressedexperimental information
now exists that asbestos was first shown to cause cancer in
laboratory animals (144,145) approximately 12 yearsbefore the
epidemiological evidencewasmadeknownandpublished(146).
Interim reportnotedthat81.8percentofanimals [mice] exposed
to asbestos had developed lung tumors, an overly high rate.
HereistoDavid Rall, ascientist andphysiciandedicatedtothepublic health
ofthe individual, ofthe nation, and ofthe world.
I appreciatethehelpful comments madeonthis paperby Kamal Abdo, J. Carl
Barrett, Jeffrey Boyd, John Bucher, Willie Lijinsky, Ronald Melnick, Jerrold
Ward, and Lauren Zeise. Donna Mayerhelped with verifying referencesandcita-
tions. Theseviews, however, aswellasthelistofchemicals inTable 1, thedefini-
tions in Table2, and the issue given in Table 5, are mine.
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